TRIM25 and hepatocellular carcinoma: TRIM25 contributes to the survival and the growth of hepatoma cells via targeting the Keap1-Nrf2 pathway, and highly expressed TRIM25 predicts the unfavorable prognosis of patients with liver carcinoma [22].